Edition:
United Kingdom

OrthoPediatrics Corp (KIDS.OQ)

KIDS.OQ on NASDAQ Stock Exchange Global Market

45.65USD
4:48pm GMT
Change (% chg)

$0.61 (+1.34%)
Prev Close
$45.05
Open
$45.05
Day's High
$46.31
Day's Low
$45.05
Volume
8,085
Avg. Vol
23,293
52-wk High
$47.82
52-wk Low
$14.06

Latest Key Developments (Source: Significant Developments)

Orthopediatrics Corp Reports Fourth Quarter And Full Year 2018 Financial Results
Wednesday, 6 Mar 2019 

March 6 (Reuters) - OrthoPediatrics Corp ::. REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.19.Q4 REVENUE $14.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $14.2 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $-0.19 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE UP 21 TO 23 PERCENT.SEES FY 2019 CONSIGNED SET INVESTMENTS IN A RANGE OF $15.0 MILLION TO $17.0 MILLION.  Full Article

Orthopediatrics Corp Announces Global Launch Of New Bandloc Duo
Monday, 25 Feb 2019 

Feb 25 (Reuters) - OrthoPediatrics Corp ::ORTHOPEDIATRICS CORP. ANNOUNCES GLOBAL LAUNCH OF NEW BANDLOC DUO.  Full Article

Orthopediatrics Corp Sees FY 2018 Revenue Up 26 Percent
Monday, 7 Jan 2019 

Jan 7 (Reuters) - OrthoPediatrics Corp ::ORTHOPEDIATRICS CORP. ANNOUNCES PRELIMINARY UNAUDITED REVENUE FOR FOURTH QUARTER AND FULL YEAR 2018.SEES FY 2018 REVENUE $57.5 MILLION TO $57.7 MILLION.SEES Q4 2018 REVENUE $14.5 MILLION TO $14.7 MILLION.SEES FY 2018 REVENUE UP 26 PERCENT.FY2018 REVENUE VIEW $57.2 MILLION -- REFINITIV IBES DATA.Q4 REVENUE VIEW $14.2 MILLION -- REFINITIV IBES DATA.  Full Article

OrthoPediatrics Corp Files Sanctions Motion Against A Former Employee And Wishbone Medical Inc
Wednesday, 2 Jan 2019 

Jan 2 (Reuters) - OrthoPediatrics Corp ::ORTHOPEDIATRICS CORP. FILES SANCTIONS MOTION AGAINST A FORMER EMPLOYEE AND WISHBONE MEDICAL, INC..ORTHOPEDIATRICS - ACTIONS PART OF CO'S EXISTING LAWSUIT AGAINST VON SEGGERN & WISHBONE MEDICAL.  Full Article

Orthopediatrics Prices Common Stock Offering at $27.00/Share
Friday, 7 Dec 2018 

Dec 7 (Reuters) - OrthoPediatrics Corp ::ANNOUNCES PRICING OF OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 1.50 MILLION COMMON SHARES PRICED AT $27.00 PER SHARE.  Full Article

Orthopediatrics Corp announces proposed offering of common stock
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - OrthoPediatrics Corp ::ORTHOPEDIATRICS CORP. ANNOUNCES PROPOSED OFFERING OF COMMON STOCK.ORTHOPEDIATRICS CORP - ORTHOPEDIATRICS IS PROPOSING TO SELL 1.5 MILLION SHARES OF COMMON STOCK.ORTHOPEDIATRICS CORP - TO USE PROCEEDS TO INVEST IN IMPLANT,INSTRUMENT SETS FOR CONSIGNMENT TO ITS CUSTOMERS, FUND RESEARCH AND DEVELOPMENT ACTIVITIES, OTHERS.  Full Article

Orthopediatrics Corp. Receives FDA Clearance For Small Stature Scoliosis System With 26th Surgical System
Friday, 19 Oct 2018 

Oct 19 (Reuters) - OrthoPediatrics Corp ::ORTHOPEDIATRICS CORP. RECEIVES FDA 510(K) CLEARANCE FOR SMALL STATURE SCOLIOSIS SYSTEM WITH 26TH SURGICAL SYSTEM.ORTHOPEDIATRICS CORP - SYSTEM REPRESENTS COMPANY'S 26TH SURGICAL SYSTEM AND IS EXPECTED TO LAUNCH IN Q4 OF 2018.  Full Article

Orthopediatrics Q2 Loss Per Share $0.21
Wednesday, 8 Aug 2018 

OrthoPediatrics Corp ::. REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.21.Q2 REVENUE $15.1 MILLION VERSUS I/B/E/S VIEW $14.2 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.14 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE UP 23 TO 24 PERCENT.AS OF JUNE 30, CASH AND CASH EQUIVALENTS WERE $26.5 MILLION, VERSUS $34.6 MILLION AS OF MARCH 31.  Full Article

Orthopediatrics Announces Preliminary Revenue For Q4
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Orthopediatrics Corp ::ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER AND FULL YEAR 2017.SEES Q4 REVENUE $11.5 MILLION TO $11.7 MILLION.SEES FY 2017 REVENUE $45.4 MILLION TO $45.6 MILLION.SEES FY 2017 REVENUE UP 22 PERCENT.FY2017 REVENUE VIEW $45.1 MILLION -- THOMSON REUTERS I/B/E/S.Q4 REVENUE VIEW $11.2 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Orthopediatrics Reports third quarter 2017 financial results
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Orthopediatrics Corp :Orthopediatrics Corp. Reports third quarter 2017 financial results.Q3 revenue rose 22 percent to $12.4 million.Q3 loss per share $1.70.  Full Article